Eye Health News and Research

Latest Eye Health News and Research

Mayo Clinic to establish pencil beam proton scanning facilities in Minnesota, Arizona and Florida

Mayo Clinic today announced plans to establish the Mayo Clinic Proton Beam Therapy Program as part of Mayo's national three-site cancer center in Minnesota, Arizona and Florida. The new program will employ intensity modulated proton therapy — based on pencil beam scanning — which is a more precise form of proton therapy treatment that allows greater control over radiation doses, shorter treatment times and fewer side effects. It is also believed to be more cost effective in selected patients.

17 Nov 2010

Artificial retinas, thought-controlled devices and brain stimulation therapy show promise

Two experimental brain-machine technologies - deep brain stimulation coupled with physical therapy and a thought-controlled computer system-may offer new therapies for people with stroke and brain injuries, new human research shows. In addition, an animal study shows a new artificial retina may restore vision better than existing prosthetics. The findings were announced today at Neuroscience 2010, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news on brain science and health.

17 Nov 2010

Video game-based technologies allow new insight into memory, perception and motor control

New tools inspired by video games are revealing how the brain senses and responds to its surroundings, finds new human and animal research. Taking advantage of state-of-the art technologies to track and mimic real-life environments, these studies show with new detail how the brain navigates, identifies, and remembers a setting. In additional human research, scientists apply these same technological advances to help people who have experienced strokes regain skills.

17 Nov 2010

New findings suggest brain sensory regions overlap to help people interpret environment

New research indicates that the integration of senses and functions in the brain is common. About two percent of the population has a condition called synesthesia, in which two different sensations, like color and sound, are experienced at once.

17 Nov 2010

New AAC devices can help patients with neurological conditions to communicate

Though many people suffering from neurological conditions such as cerebral palsy and Lou Gehrig's disease have lost their ability to speak, they can communicate using augmentative and alternative communications (AAC) devices such as keyboards, head sticks, and other hands-free options.

17 Nov 2010

Study reveals true effects of malaria on African generations

Almost a third of cerebral malaria survivors developed epilepsy or other behavioral disorders in the most comprehensive study to date of the disease in African children, solidifying the link between malaria and neuropsychiatric disorders that affect hundreds of thousands of children.

17 Nov 2010

Maine has most improved health care quality; Kansas needs more dentists

Maine Public Broadcasting Network News: "Nationwide, Maine is most improved when it comes to health care quality, according to 2009 statistics from the federal Agency for Healthcare Research and Quality. In one year, Maine jumped from 12th place to fourth best in categories ranging from cancer to patient safety, from maternal and child health to long-term care.

17 Nov 2010

Avedro's KXL System for corneal cross-linking granted European CE Mark

Avedro, Inc., sponsor of two completed US FDA multi-center clinical trials for corneal cross-linking, today announced that its KXL™ System for performing accelerated corneal cross-linking (KXL) has received the European Union's CE Mark. The CE Mark certifies that the KXL System has met the EU's health and safety standards and opens the door to immediate commercialization across the European Economic Community and in other countries recognizing the CE Mark.

17 Nov 2010

SMI launches high-speed remote eye tracker

Just in time for the SfN Neuroscience 2010 Conference in San Diego, USA, SMI launches the RED500. The RED500 is the world's first high-performance and high-speed remote eye tracker, with 500Hz sampling rate, binocular tracking and a large tracking range.

16 Nov 2010

Fisetin slows onset of motor problems, delays death in three models of Huntington's disease: Study

Fisetin, a naturally occurring compound found in strawberries and other fruits and vegetables, slows the onset of motor problems and delays death in three models of Huntington's disease, according to researchers at the Salk Institute for Biological Studies. The study, published in the online edition of Human Molecular Genetics, sets the stage for further investigations into fisetin's neuroprotective properties in Huntington's and other neurodegenerative conditions.

16 Nov 2010

Millions of Americans suffer unnecessarily with itchy, gritty, watery eyes, say allergists

Millions of Americans suffer unnecessarily with itchy, gritty, watery eyes, according to allergists at the annual scientific meeting of the American College of Allergy, Asthma and Immunology in Phoenix, Nov. 11-16. The underdiagnosis, undertreatment and self-treatment of eye allergies may seriously diminish quality of life, allergists say.

16 Nov 2010

Shire announces FDA approval of Vyvanse Capsules CII for ADHD in adolescents

Shire plc, the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) approved the prescription medication Vyvanse® (lisdexamfetamine dimesylate) Capsules CII for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents ages 13 to 17. The approval is based on study data demonstrating that Vyvanse improved ADHD symptoms compared to placebo in adolescents with ADHD. Vyvanse is also indicated for the treatment of ADHD in children ages 6 to 12 years, and adults.

15 Nov 2010

RXi third quarter net loss increases to $4.1 million

RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, today reported its financial results for the third quarter ended September 30, 2010.

15 Nov 2010

PGxHealth presents results from studies using FAMILION genetic testing at 2010 AHA

Clinical Data, Inc., today announced that results of studies using its FAMILION® genetic testing were presented at the 2010 American Heart Association (AHA) meeting. PGxHealth, a division of Clinical Data, together with its collaborators, presented results from the largest, most comprehensive studies of genetic variation associated with certain cardiac conditions that were revealed using FAMILION testing.

15 Nov 2010

New AccuDetect software reduces false-positive rates during mammography screening

Parascript, LLC, the image analysis and pattern recognition technology provider, today announced the release of AccuDetect 4.0, the next generation of its computer-aided detection (CAD) software with significant performance improvements and a greater potential for lowering false-positive rates when detecting suspicious lesions on mammograms, compared to the previous version of the product.

15 Nov 2010

Menicon announces distribution agreement with Optimed

Menicon Co., Ltd. has announced its agreement with Optimed Ltd. to become the exclusive distributor for Optimed's CAPTIV8 communication services and i-Vue content-driven digital signage software for North America. Earlier this year, Menicon obtained exclusive distribution rights for Optimed's products in Japan and Taiwan.

15 Nov 2010

WHO endorses low tech, low cost, rapid test for multi-drug resistant TB

A rapid, low cost test for diagnosing tuberculosis (TB) - including multi-drug resistance - has been endorsed by the World Health Organisation (WHO) for use in resource-poor settings.

15 Nov 2010

Freedom Meditech announces clinical study results of I-SugarX non-invasive glucose monitoring system

Freedom Meditech, Inc., the developer of non-invasive, ophthalmic-based products to detect and manage diabetes, today announced results of a clinical study that showed a high correlation between low to high blood glucose levels and non-invasive glucose measurements in the eye in a live animal model.

12 Nov 2010

NovaBay third quarter net loss increases to $1.6 million

NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, has reported third quarter financial results and highlighted the clinical progress of its in-house programs.

12 Nov 2010

Neuroscience of magic

The unorthodox research collaboration between two Barrow Neurological Institute scientists and some of the world's greatest magicians is detailed in a new book called Sleights of Mind.

12 Nov 2010

Eye Health News and Research

Latest Eye Health News and Research

Mayo Clinic to establish pencil beam proton scanning facilities in Minnesota, Arizona and Florida

Artificial retinas, thought-controlled devices and brain stimulation therapy show promise

Video game-based technologies allow new insight into memory, perception and motor control

New findings suggest brain sensory regions overlap to help people interpret environment

New AAC devices can help patients with neurological conditions to communicate

Study reveals true effects of malaria on African generations

Maine has most improved health care quality; Kansas needs more dentists

Avedro's KXL System for corneal cross-linking granted European CE Mark

SMI launches high-speed remote eye tracker

Fisetin slows onset of motor problems, delays death in three models of Huntington's disease: Study

Millions of Americans suffer unnecessarily with itchy, gritty, watery eyes, say allergists

Shire announces FDA approval of Vyvanse Capsules CII for ADHD in adolescents

RXi third quarter net loss increases to $4.1 million

PGxHealth presents results from studies using FAMILION genetic testing at 2010 AHA

New AccuDetect software reduces false-positive rates during mammography screening

Menicon announces distribution agreement with Optimed

WHO endorses low tech, low cost, rapid test for multi-drug resistant TB

Freedom Meditech announces clinical study results of I-SugarX non-invasive glucose monitoring system

NovaBay third quarter net loss increases to $1.6 million

Neuroscience of magic

Genetics & Genomics - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Eye Health News and Research

Latest Eye Health News and Research

Genetics & Genomics - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in